BioNTech SE (BNTX) Raw Materials (2018 - 2021)

BioNTech SE (BNTX) has 4 years of Raw Materials data on file, last reported at $284.0 million in Q4 2021.

• For the quarter ending Q4 2021, Raw Materials rose 437.78% year-over-year to $284.0 million; the trailing twelve-month figure through Dec 2021 stood at $284.0 million (up 437.78% YoY), and the FY2021 full-year result was $293.8 million, up 480.93% from the prior year.
• Raw Materials advanced to $284.0 million in Q4 2021, from $52.8 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $284.0 million in Q4 2021 to a low of $5.1 million in Q4 2018.
• A 4-year average of $87.8 million and a median of $30.9 million in 2020 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials surged 77.72% in 2019 and surged 481.86% in 2020, its largest moves.
• Tracing BNTX's Raw Materials over 4 years: stood at $5.1 million in 2018, then surged by 77.72% to $9.1 million in 2019, then surged by 481.86% to $52.8 million in 2020, then soared by 437.78% to $284.0 million in 2021.
• Business Quant data shows BNTX's Raw Materials at $284.0 million in Q4 2021, $52.8 million in Q4 2020, and $9.1 million in Q4 2019.